BOEHRINGER INGELHEIM RCV GMBH has a total of 126 patent applications. It decreased the IP activity by 11.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, chemical engineering and foods and drinks are BIORIGHT WORLDWIDE COMPANY LTD, CLONTECH LAB INC and FANG XIANGMING.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 23 | |
#2 | EPO (European Patent Office) | 19 | |
#3 | WIPO (World Intellectual Property Organization) | 14 | |
#4 | Republic of Korea | 12 | |
#5 | Singapore | 12 | |
#6 | United States | 12 | |
#7 | Canada | 11 | |
#8 | China | 9 | |
#9 | Japan | 6 | |
#10 | Brazil | 2 | |
#11 | Israel | 2 | |
#12 | Argentina | 1 | |
#13 | Hong Kong | 1 | |
#14 | Norway | 1 | |
#15 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Chemical engineering | |
#3 | Foods and drinks | |
#4 | Computer technology | |
#5 | Control | |
#6 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Fermentation | |
#3 | Peptides | |
#4 | Separation | |
#5 | Chemical or physical processes | |
#6 | Enzymes | |
#7 | Flotation | |
#8 | Computational chemistry | |
#9 | Control or regulating systems | |
#10 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Jungbauer Alois | 30 |
#2 | Mattanovich Diethard | 26 |
#3 | Gasser Brigitte | 26 |
#4 | Hahn Rainer | 21 |
#5 | Trefilov Alexandru | 19 |
#6 | Buchetics Markus | 18 |
#7 | Striedner Gerald | 15 |
#8 | Grabherr Reingard | 13 |
#9 | Ascher Christine | 11 |
#10 | Urthaler Jochen | 11 |
Publication | Filing date | Title |
---|---|---|
WO2021028590A1 | Caspase-2 variants | |
AU2019337392A1 | Inducible expression system for plasmid-free production of a protein of interest | |
SG11202012529VA | Means and methods for increased protein expression by use of transcription factors | |
KR20190140939A | Recombinant host cell with altered membrane lipid composition | |
SG11201808401QA | Real time monitoring of product purification | |
WO2016174258A1 | Means and methods for protein production | |
EP3132028A2 | Recombinant host cell engineered to overexpress helper proteins | |
WO2015158800A1 | Recombinant host cell for expressing proteins of interest | |
CN105764914A | Novel adsorbent composition and use thereof | |
EP2952584A1 | Improved protein production | |
AU2012222502A1 | Liquid phase separation of plasmid DNA isoforms and topoisomers | |
AU2011253661A1 | Production of recombinant proteins by autoproteolytic cleavage of a fusion protein | |
US2011269184A1 | Method for controlling plasmid copy number in e.coli | |
CA2687170A1 | Method for producing a recombinant protein on a manufacturing scale | |
EP2088196A1 | Methods and devices for producing biomolecules | |
EP1845103A1 | Method for refolding a protein |